<?xml version="1.0" encoding="UTF-8"?>
<p>According to the results of the FilmArray RP panel, 98, 98, and 74 patients were assigned to the Flu A/B virus detected group, non-Flu A/B virus pathogen detected group, and nonpathogen detected group, respectively. Antibiotic prescription rates were significantly different among the three groups (
 <italic>χ</italic>
 <sup>
  <italic>2</italic>
 </sup> = 37.1, 
 <italic>P</italic> &lt; 0.001), with the highest rate of 50.0% occurring in nonpathogen detected patients (
 <xref rid="tab3" ref-type="table">Table 3</xref>). Between patients with a non-Flu A/B virus pathogen detected and those who were in the nonpathogen detected group, there was a significant difference in antibiotic prescription rates (28.8% and 51.4%, respectively (
 <italic>χ</italic>
 <sup>
  <italic>2</italic>
 </sup> = 8.2, 
 <italic>P</italic> &lt; 0.001)). The differences in anti-influenza prescription rates were also significant among the three groups (
 <italic>χ</italic>
 <sup>
  <italic>2</italic>
 </sup> = 98.8, 
 <italic>P</italic> &lt; 0.001), with those with Flu A or Flu B receiving the most prescriptions (71.6%). Anti-influenza prescription rates were no different between patients with a non-Flu A/B virus pathogen detected and those in the nonpathogen detected group (3.1% and 8.1%, respectively, ( 
 <italic>χ</italic>
 <sup>
  <italic>2</italic>
 </sup> = 1.8, 
 <italic>P</italic>=0.194)). More detailed information is shown in 
 <xref rid="tab3" ref-type="table">Table 3</xref>.
</p>
